TickerFactsScreenerDevelopers

Lineage Cell Therapeutics, Inc. (LCTX) — Net Income

Annual figures by fiscal year, from SEC filings.

2009: -$5.14M2010: -$11.18M2011: -$16.52M2012: -$21.43M2013: -$43.88M2014: -$36.41M2015: -$46.99M2016: $33.57M2017: -$19.98M2018: -$45.99M2019: -$11.71M2020: -$20.65M2021: -$43.02M2022: -$26.27M2023: -$21.49M2024: -$18.61M2025: -$63.53M-$63.53M
2009Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$63.53M-241.4%
2024-$18.61M+13.4%
2023-$21.49M+18.2%
2022-$26.27M+38.9%
2021-$43.02M-108.3%
2020-$20.65M-76.4%
2019-$11.71M+74.5%
2018-$45.99M-130.2%
2017-$19.98M-159.5%
2016$33.57M+171.4%
2015-$46.99M-29.1%
2014-$36.41M+17.0%
2013-$43.88M-104.8%
2012-$21.43M-29.7%
2011-$16.52M-47.7%
2010-$11.18M-117.4%
2009-$5.14M—